See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
Biophytis S A PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Earlier from Biophytis Sa
- Biophytis S A: LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics
- Biophytis S A: ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
- Biophytis S A: increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
- Biophytis S A: conclut un accord stratégique en Asie et sécurise 20 M$ pour le lancement de sa Phase 3 dans la sarcopénie